Companies / Emergent BioSolutions Inc / Activity
Activity — Emergent BioSolutions Inc
64 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Lindahl Richard S Executive | Other | Common Stock | $504.0K | -46K -15.83% | 245,342 0.48% of shares | low |
| Feb 6, 2026 | Glessner Coleen Executive | Other | Common Stock | $315.0K | -29K -19.99% | 115,472 0.23% of shares | low |
| Mar 5, 2026 | Papa Joseph C CEO | Other | Common Stock | $312.7K | -37K -10.82% | 305,445 0.60% of shares | low |
| Mar 5, 2026 | Lindahl Richard S Executive | Other | Common Stock | $199.6K | -24K -9.89% | 215,367 0.42% of shares | low |
| May 1, 2026 | Zoon Kathryn C Director | Sell | Common Stock | $135.0K | -16K -16.62% | 80,998 0.16% of shares | medium |
| Apr 30, 2026 | Katkin Keith Director | Sell | Common Stock | $128.2K | -15K -13.85% | 96,294 0.19% of shares | medium |
| May 1, 2026 | DeGolyer Donald W Director | Sell | Common Stock | $121.4K | -15K -10.00% | 130,675 0.25% of shares | medium |
| May 1, 2026 | Dayal Sujata Tyagi Director | Sell | Common Stock | $106.8K | -13K -11.18% | 101,543 0.20% of shares | medium |
| Feb 6, 2026 | Williams Paul Anthony Executive | Other | Common Stock | $94.5K | -9K -10.08% | 77,216 0.15% of shares | low |
| Mar 5, 2026 | Lowry Simon C Executive | Other | Common Stock | $89.8K | -11K -12.03% | 77,803 0.15% of shares | low |
| Mar 5, 2026 | Hartzel William Executive | Other | Common Stock | $80.1K | -9K -9.82% | 87,188 0.17% of shares | low |
| Mar 5, 2026 | Williams Paul Anthony Executive | Other | Common Stock | $79.3K | -9K -12.35% | 66,681 0.13% of shares | low |
| Mar 5, 2026 | Glessner Coleen Executive | Other | Common Stock | $69.2K | -8K -7.30% | 104,108 0.20% of shares | low |
| Feb 6, 2026 | Hartzel William Executive | Other | Common Stock | $63.0K | -6K -5.60% | 97,311 0.19% of shares | low |
| Feb 6, 2026 | Lindahl Richard S Executive | Other | Common Stock | $61.6K | -6K -2.30% | 239,700 0.47% of shares | low |
| Mar 5, 2026 | Perl Jessica Executive | Other | Common Stock | $54.6K | -6K -9.58% | 61,004 0.12% of shares | low |
| Mar 3, 2026 | Fowler John D Jr Director | Grant | Common Stock | $45.0K | +5K | 5,006 <0.01% of shares | low |
| Apr 1, 2026 | Williams Paul Anthony Executive | Sell | Common Stock | $33.8K | -4K -6.00% | 62,681 0.12% of shares | low |
| Jun 8, 2026 | Lindahl Richard S Executive | Other | Common Stock | $31.7K | -4K -1.05% | 374,083 0.73% of shares | low |
| Feb 6, 2026 | Glessner Coleen Executive | Other | Common Stock | $31.1K | -3K -2.47% | 112,620 0.22% of shares | low |
| Jun 8, 2026 | Glessner Coleen Executive | Other | Common Stock | $16.1K | -2K -0.99% | 202,201 0.39% of shares | low |
| Jun 8, 2026 | Hartzel William Executive | Other | Common Stock | $13.9K | -2K -0.93% | 185,558 0.36% of shares | low |
| Feb 6, 2026 | Williams Paul Anthony Executive | Other | Common Stock | $11.2K | -1K -1.32% | 76,194 0.15% of shares | low |
| Feb 9, 2026 | Perl Jessica Executive | Other | Common Stock | $10.1K | -918 -1.34% | 67,469 0.13% of shares | low |
| May 1, 2026 | Zoon Kathryn C Director | Sell | Common Stock | $9.5K | -1K -1.31% | 79,941 0.16% of shares | low |
| May 1, 2026 | Dayal Sujata Tyagi Director | Sell | Common Stock | $8.8K | -980 -0.97% | 100,563 0.20% of shares | low |
| May 1, 2026 | DeGolyer Donald W Director | Sell | Common Stock | $8.5K | -954 -0.73% | 129,721 0.25% of shares | low |
| Feb 6, 2026 | Hartzel William Executive | Other | Common Stock | $6.9K | -630 -0.65% | 96,681 0.19% of shares | low |
| Mar 1, 2026 | Lindahl Richard S Executive | Other | Common Stock | $5.6K | -683 -0.28% | 239,017 0.47% of shares | low |
| Jun 8, 2026 | Williams Paul Anthony Executive | Other | Common Stock | $5.6K | -694 -0.43% | 162,098 0.32% of shares | low |
| Mar 1, 2026 | Glessner Coleen Executive | Other | Common Stock | $2.6K | -313 -0.28% | 112,307 0.22% of shares | low |
| Mar 1, 2026 | Williams Paul Anthony Executive | Other | Common Stock | $945 | -116 -0.15% | 76,078 0.15% of shares | low |
| Apr 30, 2026 | Zoon Kathryn C Director | Grant | Common Stock | $0 | +25K +35.30% | 97,143 0.19% of shares | low |
| Apr 30, 2026 | DeGolyer Donald W Director | Grant | Common Stock | $0 | +25K +21.14% | 145,202 0.28% of shares | low |
| Apr 30, 2026 | Dayal Sujata Tyagi Director | Grant | Common Stock | $0 | +25K +28.48% | 114,324 0.22% of shares | low |
| Apr 30, 2026 | Fowler Neal Franklin Director | Grant | Common Stock | $0 | +25K +18.70% | 160,847 0.31% of shares | low |
| Apr 30, 2026 | White Marvin L Director | Grant | Common Stock | $0 | +25K +28.64% | 113,839 0.22% of shares | low |
| Apr 30, 2026 | Harsanyi Zsolt Executive | Grant | Common Stock | $0 | +25K +20.48% | 149,076 0.29% of shares | low |
| Apr 30, 2026 | Richard Ronald Director | Grant | Common Stock | $0 | +25K +25.75% | 123,761 0.24% of shares | low |
| Apr 29, 2026 | Lowry Simon C Executive | Grant | Common Stock | $0 | +100K +128.67% | 177,914 0.35% of shares | low |
| Apr 29, 2026 | Perl Jessica Executive | Grant | Common Stock | $0 | +104K +170.94% | 165,286 0.32% of shares | low |
| Apr 29, 2026 | Hartzel William Executive | Grant | Common Stock | $0 | +100K +114.82% | 187,299 0.37% of shares | low |
| Apr 29, 2026 | Williams Paul Anthony Executive | Grant | Common Stock | $0 | +100K +159.72% | 162,792 0.32% of shares | low |
| Apr 29, 2026 | Glessner Coleen Executive | Grant | Common Stock | $0 | +100K +96.16% | 204,219 0.40% of shares | low |
| Apr 30, 2026 | Katkin Keith Director | Grant | Common Stock | $0 | +25K +29.32% | 111,775 0.22% of shares | low |
| Apr 29, 2026 | Papa Joseph C CEO | Grant | Common Stock | $0 | +188K +61.45% | 493,153 0.96% of shares | low |
| Apr 29, 2026 | Lindahl Richard S Executive | Grant | Common Stock | $0 | +163K +75.54% | 378,047 0.74% of shares | low |
| Apr 30, 2026 | Fowler John D Jr Director | Grant | Common Stock | $0 | +25K +506.27% | 30,350 0.06% of shares | low |
| Apr 30, 2026 | Zoon Kathryn C Director | Grant | Stock Option (Right to Buy) | — | +11K | 11,296 0.02% of shares | low |
| Apr 30, 2026 | DeGolyer Donald W Director | Grant | Stock Option (Right to Buy) | — | +11K | 11,296 0.02% of shares | low |